Breakfast Activity/Non-CE Accredited Satellite Symposium: An Outpatient Treatment Option for Patients with 3L+ Follicular Lymphoma, A Fixed-Duration Treatment Option for 3L+ Diffuse Large B-Cell Lymphoma
Genentech
Seating is available on a first-come, first-served basis.